XML 48 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2013
Apr. 01, 2012
Revenues $ 21,019 $ 27,501
Cost of products sold 14,640 20,908
Gross profit 6,379 6,593
Operating expenses:    
Research and development (including $56 and $65, respectively, of amortization of intangible assets) 1,369 2,139
Selling, general, and administrative (including $45 and $60, respectively, of amortization of intangible assets) 4,635 5,743
Total operating expenses 6,004 7,882
Operating income (loss) 375 (1,289)
Other income (expense):    
Interest income 2 1
Interest expense (90) (104)
Miscellaneous (25) 52
Income (loss) from continuing operations before income taxes 262 (1,340)
Income tax provision-current 38 79
Income tax provision-deferred 60 12
Total income taxes provision 98 91
Net income (loss) from continuing operations 164 (1,431)
Discontinued operations:    
Income (loss) from discontinued operations, net of tax 264 (71)
Net income (loss) 428 (1,502)
Net (income) loss attributable to noncontrolling interest 6  
Net income (loss) attributable to Ultralife 434 (1,502)
Other comprehensive income (loss):    
Foreign currency translation adjustments (127) 148
Comprehensive income (loss) attributable to Ultralife $ 307 $ (1,354)
Net income (loss) attributable to Ultralife common shareholders - basic    
Continuing operations (in Dollars per share) $ 0.01 $ (0.08)
Discontinued operations (in Dollars per share) $ 0.02 $ (0.01)
Total (in Dollars per share) $ 0.02 $ (0.09)
Net income (loss) attributable to Ultralife common shareholders - diluted    
Continuing operations (in Dollars per share) $ 0.01 $ (0.08)
Discontinued operations (in Dollars per share) $ 0.02 $ (0.01)
Total (in Dollars per share) $ 0.02 $ (0.09)
Weighted average shares outstanding - basic (in Shares) 17,457,000 17,358,000
Weighted average shares outstanding - diluted (in Shares) 17,478,000 17,358,000